ダウンロード数: 129

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
26_0265.pdf470.83 kBAdobe PDF見る/開く
タイトル: 膀胱癌患者における血清蛋白の変動
その他のタイトル: DYSPROTEINEMIA IN PATIENTS WITH BLADDER CANCER
著者: 久住, 治男  KAKEN_name
中鳴, 和喜  KAKEN_name
塚原, 健治  KAKEN_name
黒田, 恭一  KAKEN_name
右田, 俊介  KAKEN_name
著者名の別形: Hisazumi, Haruo
Nakajima, Kazuyoshi
Tsukahara, Kenji
Kuroda, Kyoichi
Migita, Shunsuke
発行日: Mar-1980
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 26
号: 3
開始ページ: 265
終了ページ: 271
抄録: Using a micro-single radial immuncdifusion method, quantitative studies have been made on the serum proteins of bladder cancer patients; 11 patients in the early stage of tumors and 17 patients m the advanced stage. In the early group, 12 proteins (α1AT, α1X, Hp, Cp, IgG, β2III , β2I, IgA, Znα2, C9, C5, βLP) were significantly elevated. In the advanced group, 14 proteins (α1AT, α1AG, α1a, X, Znα2, Hp, Cp, C9, CP3A, C5, β2IIl, C4, βLp, ClsI, IgA) significantly increased and 6 proteins (Pre, Alb, α2HS, α2M, Tf, Pm) significantly decreased. This group showed a significant increase of C9, α1AG and C3PA and a significant decrease of Pre, Alb, α2HS, α2M and Tf as compared with the early stage group. It was assumed that these alterations have a possible usefulness in estimating the stage of tumors or prognosis of disease. There was a significant correlation between C9 andα1AT in all the 28 patients. A possible clinical significance of the alterations of the complement, coagulation, and fibrinolysis systems in cancer patients is mainly discussed.
URI: http://hdl.handle.net/2433/122616
出現コレクション:Vol.26 No.3

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。